Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-01-06
1994-03-22
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3136
Patent
active
052965074
ABSTRACT:
A method for the treatment of dementia and cerebrovascular disorders and for inhibiting platelet aggregation in patients in need thereof comprising the step of administering a therapeutically effective amount of a 1-[3-(dimethylamino)propyl]-1-phenylphthalane of the general formula ##STR1## wherein R.sup.1 and R.sup.2 each are selected from the group consisting of halogen, trifluoromethyl, cyano and R--CO--, wherein R is an alkyl radical, or a pharmaceutically-acceptable acid addition salt thereof, is described.
REFERENCES:
Folia Haematol. Leipzig, vol. 115, No. 4, 1988, pp. 475-478, Heptinstall, et al., "How can we inhibit 5-HT-induced platelet aggregation and why should we bother?"
Archives of Pharmacology, vol. 334, No. 4, Dec. 1986, Springer International, pp. 341-345, Bevan, et al., "Effects of combinations of 5-hydroxytryptamine receptor antagonists on 5-HT-induced human platelet aggregation".
The Journal of Biological Chemistry, vol. 260, No. 12, Jun. 25, 1985, pp. 7603-7606, The American Soc. of Biological Chemists US, Chaffoy De Courcelles, et al., "Evidence that phospholipid turnover is the signal transducing system . . . ".
Nord. Psykiatr. Tidsskr., vol. 41, No. 6, 1987, pp. 423-429, S. E. Nyth, et al., "Behandling med citalopram vid demens. Normalisering av DST".
Drugs of the Future, vol. 15, No. 6, Jun. 1990, editor J. R. Prous et al., p. 618, "Citalopram".
The British Journal of Psychiatry, vol. 157, Dec. 1990, pp. 894-901, The Royal College of Psychiatrists, Nyth, et al., "The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A nordic multicentre study".
Psychopharmacology, supplement to vol. 96, 1988, Abstracts of the XVIth C.I.N.P. Congress, Aug. 15-19, 1988, Munich, p. 45, Abstract No. TU24.04, Springer International, Gottfries, "Dementia disorders and depression in the elderly. Biochemical aspects".
Nyth, A. L. et al., "The effect of citalopram in dementia disorders. A Scandinavian multicentre study", Abstract of the XVIth C.I.N.P. Congress, Munich, Aug. 15-19, 1988.
Nyth, A. L., et al. ECNP Abstract 1989, Sweden, 79.
(Appendix C) Brane, "The GBS scale: a new rating scale for dementia syndromes", Nort Psykiatr. Tidssk, 1986, 40, 125-134.
Nyth, et al., Acta Psychiatr. Scand., 1992, 86, 138-145.
Ikeda Yugo
Kobayashi Naomi
Kurimoto Tadashi
Tanaka Yoshiaki
Friedman S. J.
H.Lundbeck A/S
Hueschen Gordon W.
LandOfFree
Treatment of cerbrovascular disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cerbrovascular disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cerbrovascular disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437421